Coronavirus (484) More deaths, no benefit from hydroxychloroquine (3)

23 April, 2020

May be we need tp look at its action differentially depending on the stage of the disease. In later stages, there is significant cardiac involvement by the disease itself and thus the drug may not do overall good. On the other hand, it may be very good for patients in very early stage

HIFA profile: Sandeep Saluja is an Internist at Saran Ashram Hospital, Dayalbagh, Agra, India. He is also a Rheumatologist and was earlier with the All India Institute of Medical Sciences. He has volunteered to work in remote inaccesible parts of India for no personal or commercial reasons. He is a member of the HIFA working group on Information for Prescribers and Users of Medicines. www.hifa.org/projects/prescribers-and-users-medicines

http://www.hifa.org/support/members/sandeep

Twitter @doctorsaluja doctorsaluja AT gmail.com